← back to search

Shengmeng Peng

Sun Yat-sen University · CN
🔎 Find collaborators in Molecular Biology · Pulmonary and Respiratory Medicine →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Molecular Biology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Prostate Cancer Treatment and Research, Bladder and Urothelial Cancer Treatments, RNA modifications and cancer, and RNA Research and Splicing.
h-index
13
citations
694
works
33
NIH funding
primary concept
email

Recent publications

Engineering CRISPR System‐Based Bacterial Outer Membrane Vesicle Potentiates T Cell Immunity for Enhanced Cancer Immunotherapy
Advanced Materials 2025cited by 17position: middledoi
PTBP1 Regulates DNMT3B Alternative Splicing by Interacting With RALY to Enhance the Radioresistance of Prostate Cancer
Advanced Science 2024cited by 14position: middledoi
UBE2S interacting with TRIM21 mediates the K11-linked ubiquitination of LPP to promote the lymphatic metastasis of bladder cancer
Cell Death and Disease 2023cited by 47position: middledoi
TSPAN18 facilitates bone metastasis of prostate cancer by protecting STIM1 from TRIM32-mediated ubiquitination
Journal of Experimental & Clinical Cancer Research 2023cited by 30position: middledoi
HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5‐WDR5‐dependent transcriptional program
Cancer Communications 2022cited by 116position: middledoi
UBE2S as a novel ubiquitinated regulator of p16 and β-catenin to promote bone metastasis of prostate cancer
International Journal of Biological Sciences 2022cited by 49position: firstdoi
Comprehensive analysis of TP53 and SPOP mutations and their impact on survival in metastatic prostate cancer
Frontiers in Oncology 2022cited by 17position: middledoi
Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer
Journal of Experimental & Clinical Cancer Research 2021cited by 96position: middledoi
WD repeat domain 5 promotes chemoresistance and Programmed Death-Ligand 1 expression in prostate cancer
Theranostics 2021cited by 86position: middledoi
NONO Inhibits Lymphatic Metastasis of Bladder Cancer via Alternative Splicing of SETMAR
Molecular Therapy 2020cited by 91position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xu Chen · University of Southern California9 papers (2020–2025)Ruihui Xie · Sun Yat-sen University6 papers (2020–2024)Qianghua Zhou · University Health Network6 papers (2020–2023)Tianxin Lin · State Key Laboratory of Oncology in South China6 papers (2021–2025)Ming Huang · Tianjin University of Traditional Chinese Medicine6 papers (2020–2023)Jian Huang · Zunyi Medical University3 papers (2020–2023)Yuelong Chen · Chinese University of Hong Kong3 papers (2020–2022)Jian Huang · Harbin Medical University3 papers (2021–2022)Liang Cheng · State Key Laboratory of Chemical Engineering3 papers (2021–2024)Jingtong Zhang · Sun Yat-sen University3 papers (2020–2021)Haixia He · Multimeric Biotherapeutics (United States)3 papers (2021–2024)Siting Chen · Fujian Medical University3 papers (2022–2025)Junlin Lu · Sun Yat-sen University2 papers (2023–2025)Xuwei Hong · Shantou University2 papers (2023–2025)Liang Cheng · Bengbu Medical College2 papers (2020–2022)Sen Liu · Chengdu Medical College2 papers (2021–2024)Qiang Zhang · Meizhou City People's Hospital2 papers (2022–2022)Yiming Lai · Xinjiang Medical University2 papers (2022–2022)Zhenghui Guo · Sun Yat-sen University2 papers (2022–2022)Tianxin Lin · Sun Yat-sen University2 papers (2020–2024)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Molecular Biology · Pulmonary and Respiratory Medicine →